Agouron Pharmaceuticals, Inc.
Records under this name other than the patents Agouron Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Back to Agouron Pharmaceuticals, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,858,643 | Enantiomerically Pure Aminoheteroaryl Compounds as Protein Kinase Inhibitors Formerly held In force · High confidence | In force | High confidence | |
| US 7,268,126 | Polymorphic and Amorphous Forms of the Phosphate Salt of 8-Fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6H-azepino[5,4,3-ce]indol-6-one Term ended Term ended Sep 21, 2025 · High confidence | Term ended | Term ended Sep 21, 2025 | High confidence |
| US 7,323,562 | Method of Preparing Poly(ADP-RIBOSE) Polymerases Inhibitors Term ended Term ended Sep 21, 2025 · High confidence | Term ended | Term ended Sep 21, 2025 | High confidence |
| US 6,534,524 | Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use Term ended Term ended Apr 29, 2025 · USPTO record | Term ended | Term ended Apr 29, 2025 | USPTO record |
| US 8,785,632 | Enantiomerically Pure Aminoheteroaryl Compounds as Protein Kinase Inhibitors Formerly held Term ended Term ended Mar 1, 2025 · Low confidence | Term ended | Term ended Mar 1, 2025 | Low confidence |
| US 6,495,541 | Tricyclic inhibitors of poly(ADP-ribose) polymerases Formerly held Term ended Term ended Nov 22, 2023 · USPTO record | Term ended | Term ended Nov 22, 2023 | USPTO record |
| US 7,109,228 | Pyrazole derivatives Term ended Term ended Apr 20, 2023 · USPTO record | Term ended | Term ended Apr 20, 2023 | USPTO record |
| US 7,928,214 | P-cadherin antibodies Lapsed on the fee record Ended Apr 19, 2023 · USPTO record | Lapsed on the fee record | Ended Apr 19, 2023 | USPTO record |
| US 6,855,724 | Tropane Derivatives Useful in Therapy Held by another company Term ended Term ended Apr 7, 2023 · High confidence | Term ended | Term ended Apr 7, 2023 | High confidence |
| US 7,125,905 | Pyrrole Substituted 2-Indolinone Protein Kinase Inhibitors No holder on record Term ended Term ended Feb 15, 2021 · Low confidence | Term ended | Term ended Feb 15, 2021 | Low confidence |